Abstract
The use of blood transfusions is a mainstay of modern medical practice. Jehovah’s Witnesses decline the use of blood transfusions as a matter of faith, however, and other patients do so for personal reasons. In all cases, it is important to document what blood products can or cannot be used. It is also essential to test all patients for iron deficiency, and to address any correctable factors in those who are anemic. This article reviews a variety of options that are available to aid in caring for patients who refuse blood trans-fusions, ranging from tranexamic acid to erythropoiesis-stimulating agents. With the use of these treatments, patients who decline blood transfusion can be safely managed in situations ranging from elective surgery to stem cell transplant to pregnancy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 826-836 |
| Number of pages | 11 |
| Journal | Clinical Advances in Hematology and Oncology |
| Volume | 18 |
| Issue number | 12 |
| State | Published - Dec 2020 |
Keywords
- Blood transfusion
- Erythropoiesis-stimulating agents
- Jehovah’s Witnesses
- Tranexamic acid
ASJC Scopus subject areas
- Hematology
- Oncology